LK
Therapeutic Areas
Izun Pharmaceuticals Pipeline
| Drug | Indication | Phase |
|---|---|---|
| PeriActive™ | Periodontal disease (gingivitis, periodontitis) | Commercial |
| CURASITE™ | Chronic wounds, including diabetic foot ulcers | Commercial |
| IZN‑6N4 | Oral mucositis in cancer patients | Preclinical |
| GSM Botanical Therapy | Genitourinary Syndrome of Menopause | Preclinical |
Leadership Team at Izun Pharmaceuticals
JK
Jonathan Kalman
CEO
DW
Dr. William Levine
CSO
DA
Dr Amy Rosenbluh
Director of Production & Laboratory Manager